Electra Therapeutics, Inc. Common stock (ETRA) stock: key figures, P/E, revenue and dividend
Health Care · United States
Electra Therapeutics, Inc. Common stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Operating income | -26.32 m USD | -61.89 m USD |
| EBIT | -24.79 m USD | -60.54 m USD |
| Net income | -24.79 m USD | -61.98 m USD |
| Diluted EPS – continuing operations | -0.39 USD | -0.99 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Electra Therapeutics, Inc. Common stock
Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel targets for diseases in immunology and cancer. Its product, ELA026, is a monoclonal antibody that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, enabling medical professionals to find an approved treatment for secondary hemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory condition. The company was incorporated in 2018 and is based in South San Francisco, California.
More stocks
- Sparebank 1 Helgeland (HELG.OL)
- Phoenix Mecano AG (PMN.SW)
- NRJ Group SA (NRG.PA)
- A.F.P. Planvital S.A. (PLANVITAL.SN)
- Tianjin Keyvia Electric Co Ltd (300407.SZ)
- Beijing Quanshi World Online Net (002995.SZ)
- Ciputra Development Tbk (CTRA.JK)
- Henan Newland Pharmaceutical Co. Ltd. A (301277.SZ)
- Ningbo Solartron Technology Co Ltd (688299.SS)
- First Farmers Financial Corp (FFMR)
- S&S TECH Corporation (101490.KQ)
- Zhejiang Jinghua Laser Technology Co Ltd Class A (603607.SS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.